Pharma Strategy Blog

Commentary on Pharma & Biotech Oncology / Hematology New Product Development

In an effort to be more visible to the public, the FDA now publishes its own 'transparency blog".  This post deals with their role in regulating orphan drugs in service of the 7000+ rare diseases.

Link here.  


Posted by Bruce Lehr June 22nd 2010.


Saw this on Bruce Lehr's Big Red Biotech blog, which I'm a fan of.

Interesting video on the FDA blog via the link his post too.

One Response to “FDA Comments on Its Role in Rare Diseases & Orphan Drugs”

Comments are closed.

error: Content is protected !!